Endotoxemia contributes to the immune paralysis in patients with cirrhosis

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 816-826

  Lin, Chun Yen ^a   Tsai, I Fan ^a   Ho, Yu Pin ^a   Huang, Ching Tai ^a   Lin, Yung Chang ^a   Lin, Chun Jung ^a   Tseng, Shu Chin ^a   Lin, Wei Pin ^a   Chen, Wei Ting ^a   Sheen, I Shyan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Endotoxin; HLA DR antigen (human leukocyte antigen DR); Immune paralysis; Interleukin 10; Tumor necrosis factor alpha

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; ENDOTOXIN; HLA DR ANTIGEN; INTERLEUKIN 10; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOTOXEMIA; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PARALYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CELLS, CULTURED; ENDOTOXEMIA; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MONOCYTES; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047149304     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.12.018     Document Type: Article

References (39)

1. Borzio M., Salerno F., Piantoni L., Cazzaniga M., Angeli P., Bissoli F., et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33 (2001) 41-48
2. Foreman M.G., Mannino D.M., and Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the national hospital discharge survey. Chest 124 (2003) 1016-1020
3. Fiuza C., Salcedo M., Clemente G., and Tellado J.M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 182 (2000) 526-533
4. Rimola A., Soto R., Bory F., Arroyo V., Piera C., and Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4 (1984) 53-58
5. Wong F., Bernardi M., Balk R., Christman B., Moreau R., Garcia-Tsao G., et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54 (2005) 718-725
6. Thalheimer U., Triantos C.K., Samonakis D.N., Patch D., and Burroughs A.K. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54 (2005) 556-563
7. von Baehr V., Docke W.D., Plauth M., Liebenthal C., Kupferling S., Lochs H., et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47 (2000) 281-287
8. Wasmuth H.E., Kunz D., Yagmur E., Timmer-Stranghoner A., Vidacek D., Siewert E., et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 42 (2005) 195-201
9. Bone R.C., Grodzin C.J., and Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112 (1997) 235-243
10. West M.A., and Heagy W. Endotoxin tolerance: a review. Crit Care Med 30 (2002) S64-S73
11. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125 (1996) 680-687
12. Tschaikowsky K., Hedwig-Geissing M., Schiele A., Bremer F., Schywalsky M., and Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30 (2002) 1015-1023
13. Ho Y.P., Sheen I.S., Chiu C.T., Wu C.S., and Lin C.Y. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 101 (2006) 1117-1124
14. Antoniades C.G., Berry P.A., Davies E.T., Hussain M., Bernal W., Vergani D., et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44 (2006) 34-43
15. Docke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3 (1997) 678-681
16. Asadullah K., Woiciechowsky C., Docke W.D., Egerer K., Kox W.J., Vogel S., et al. Very low monocytic HLA-DR expression indicates high risk of infection-immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 2 (1995) 184-190
17. Tschaikowsky K., Hedwig-Geissing M., Schiele A., Bremer F., Schywalsky M., and Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30 (2002) 1015-1023
18. Perry S.E., Mostafa S.M., Wenstone R., Shenkin A., and McLaughlin P.J. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 29 (2003) 1245-1252
19. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
20. Siedlar M., Mytar B., Krzeszowiak A., Baran J., Hyszko M., Ruggiero I., et al. Demonstration of iNOS-mRNA and iNOS in human monocytes stimulated with cancer cells in vitro. J Leukoc Biol 65 (1999) 597-604
21. Heinzelmann M., Platz A., Flodgaard H., Polk Jr. H.C., and Miller F.N. Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-{ralpha} production in human monocytes. J Immunol 162 (1999) 4240-4245
22. Perticarari S., Presani G., and Banfi E. A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 170 (1994) 117-124
23. Szollosi J., Tron L., Damjanovich S., Helliwell S.H., rndt-Jovin D., and Jovin T.M. Fluorescence energy transfer measurements on cell surfaces: a critical comparison of steady-state fluorimetric and flow cytometric methods. Cytometry 5 (1984) 210-216
24. Lin R.S., Lee F.Y., Lee S.D., Tsai Y.T., Lin H.C., Lu R.H., et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22 (1995) 165-172
25. Wolk K., Docke W.D., von Baehr V., Volk H.D., and Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96 (2000) 218-223
26. Wolk K., Kunz S., Crompton N.E.A., Volk H.D., and Sabat R. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem 278 (2003) 18030-18036
27. Chan C.C., Hwang S.J., Lee F.Y., Wang S.S., Chang F.Y., Li C.P., et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 32 (1997) 942-946
28. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915-924
29. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
30. Koppelman B., Neefjes J.J., de Vries J.E., and de Waal M.R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7 (1997) 861-871
31. Loftis L.L., Meals E.A., and English B.K. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis 175 (1997) 1008-1011
32. Qasimi P., Ming-Lum A., Ghanipour A., Ong C.J., Cox M.E., Ihle J., et al. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor {alpha} and nitric oxide production by macrophages. J Biol Chem 281 (2006) 6316-6324
33. Sachse C., Prigge M., Cramer G., Pallua N., and Henkel E. Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin Chem Lab Med 37 (1999) 193-198
34. Livingston D.H., Appel S.H., Wellhausen S.R., Sonnenfeld G., and Polk Jr. H.C. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 123 (1988) 1309-1312
35. Volk H.D., Thieme M., Heym S., Docke W.D., Ruppe U., Tausch W., et al. Alterations in function and phenotype of monocytes from patients with septic disease-predictive value and new therapeutic strategies. Behring Inst Mitt (1991) 208-215
36. Satoh A., Miura T., Satoh K., Masamune A., Yamagiwa T., Sakai Y., et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 25 (2002) 245-250
37. Haveman J.W., van den Berg A.P., van den Berk J.M., Mesander G., Slooff M.J., de Leij L.H., et al. Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis 1 (1999) 146-152
38. Morel A.S., Coulton G., and Londei M. Regulation of major histocompatibility complex class II synthesis by interleukin-10. Immunology 106 (2002) 229-236
39. Munoz C., Carlet J., Fitting C., Misset B., Bleriot J.P., and Cavaillon J.M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88 (1991) 1747-1754